Capital partnerships: Planning for long-term success
With significant capital investment in equipment and extensive associated facility modifications, Almac successfully transferred and scaled-up Ironwood Pharmaceuticals’ innovative yet challenging orally delivered peptide product, linaclotide, helping them prepare to meet global demand in multiple territories.
